SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-007415
Filing Date
2021-05-17
Accepted
2021-05-17 16:34:54
Documents
90
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ibio-20210331x10q.htm 10-Q 1946826
2 EX-31.1 ibio-20210331ex311d76c1b.htm EX-31.1 12045
3 EX-31.2 ibio-20210331ex312ec6ff3.htm EX-31.2 12028
4 EX-32.1 ibio-20210331ex32104f26d.htm EX-32.1 6656
5 EX-32.2 ibio-20210331ex3228b8d5f.htm EX-32.2 6275
  Complete submission text file 0001558370-21-007415.txt   10907441

Data Files

Seq Description Document Type Size
6 EX-101.INS ibio-20210331.xml EX-101.INS 2906245
7 EX-101.SCH ibio-20210331.xsd EX-101.SCH 76433
8 EX-101.CAL ibio-20210331_cal.xml EX-101.CAL 59521
9 EX-101.DEF ibio-20210331_def.xml EX-101.DEF 288314
10 EX-101.LAB ibio-20210331_lab.xml EX-101.LAB 517389
11 EX-101.PRE ibio-20210331_pre.xml EX-101.PRE 506479
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 21931441
SIC: 2834 Pharmaceutical Preparations